You have 9 free searches left this month | for more free features.

Acute myeloid leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Acute Myeloid Leukemia Trial (Dasatinib)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 20, 2023

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti Tim-3/CD123 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 4, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

      Not yet recruiting
      • Acute Myeloid Leukemia, in Relapse
      • Acute Myeloid Leukemia Refractory
      • (no location specified)
      Nov 9, 2023

      Acute Myeloid Leukemia Trial (ABBV-787)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Sep 29, 2023

      Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Oral azacitidine
      • Seoul, Korea, Republic of
        Bristol-Myers Squibb YH
      Oct 3, 2023

      Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

      Recruiting
      • Acute Myeloid Leukemia
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 23, 2023

      Acute Myeloid Leukemia Trial in Taipei

      Enrolling by invitation
      • Acute Myeloid Leukemia
        • Taipei, Taiwan
          National Taiwan University Hospital
        Aug 9, 2023

        Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Mitoxantrone hydrochloride liposome injection
        • +3 more
        • (no location specified)
        May 29, 2023

        Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

        Recruiting
        • Acute Myeloid Leukemia Refractory
        • Lyon, France
          Centre Léon Bérard
        Nov 30, 2023

        Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Beijing, Beijing, China
          Yuan Kong
        Sep 4, 2023

        Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Mitoxantrone hydrochloride liposome injection
        • +3 more
        • Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Jul 1, 2023

        Frequency and Risk Factors of Acute Myeloid Leukemia

        Not yet recruiting
        • Myeloid Leukemia
        • Bone marrow aspirite for diagnosis
        • (no location specified)
        Mar 15, 2023

        AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

        Not yet recruiting
        • AML
        • +11 more
        • (no location specified)
        Aug 14, 2023

        Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

        Recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • CD123 targeted CAR-NK cells
        • Taiyuan, Shanxi, China
          Shanxi Bethune Hospital
        Aug 28, 2023

        A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

        Not yet recruiting
        • C-KIT Mutation
          • (no location specified)
          Nov 2, 2023

          PET Tracer Based FDG Signal for Predicting Prognosis in Acute

          Enrolling by invitation
          • Acute Myeloid Leukemia
          • No intervention
          • Guangzhou, Guangdong, China
            First Affiliated Hospital of Jinan University
          Jun 22, 2023

          Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

          Active, not recruiting
          • Acute Myeloid Leukemia
          • +5 more
          • Duarte, California
            City of Hope Medical Center
          Jan 4, 2023

          iN the Real Practice

          Not yet recruiting
          • Acute Myeloid Leukemia (AML)
          • +2 more
          • Vyxeos liposomal
          • Roma, Italy
            Policlinico Tor Vergata
          Nov 16, 2023

          Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Houston, Texas
            MD Anderson Cancer Center
          Oct 27, 2023

          Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

          Not yet recruiting
          • Acute Myeloid Leukemia, in Relapse
          • +2 more
          • CPI 613
          • +3 more
          • Winston-Salem, North Carolina
            Wake Forest Baptist Comprehensive Cancer Center
          May 10, 2023

          Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • High-Risk and Very High-Risk Myelodysplastic Syndromes
          • (no location specified)
          Jul 25, 2023

          Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

          Recruiting
          • Refractory Acute Myeloid Leukemia
          • +4 more
          • CD371-YSNVZ-IL18 CAR T cells
          • Basking Ridge, New Jersey
          • +6 more
          Aug 29, 2023

          Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

          Not yet recruiting
          • Chemotherapy-Induced Thrombocytopenia
          • Hetrombopag Olamine
          • (no location specified)
          Jul 5, 2023